Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study.
- DOI
- 10.1016/s1474-4422(12)70056-x
- Published
- 2012 May
- Container
- The Lancet. Neurology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1474-4422-12-70056-x,
title = {Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study.},
author = {Devonshire V and Havrdova E and Radue EW and O'Connor P and Zhang-Auberson L and Agoropoulou C and Häring DA and Francis G and Kappos L and FREEDOMS study group},
year = {2012},
journal = {The Lancet. Neurology},
doi = {10.1016/s1474-4422(12)70056-x},
url = {https://doi.org/10.1016/s1474-4422(12)70056-x}
}RIS
TY - JOUR TI - Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study. AU - Devonshire V AU - Havrdova E AU - Radue EW AU - O'Connor P AU - Zhang-Auberson L AU - Agoropoulou C AU - Häring DA AU - Francis G AU - Kappos L AU - FREEDOMS study group PY - 2012 JO - The Lancet. Neurology DO - 10.1016/s1474-4422(12)70056-x UR - https://doi.org/10.1016/s1474-4422(12)70056-x ER -
APA
V, D., E, H., EW, R., P, O., L, Z., C, A., DA, H., G, F., L, K., & group, F. S. (2012). Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study.. The Lancet. Neurology. https://doi.org/10.1016/s1474-4422(12)70056-x
Source records
- pubmed · retrieved 2026-09-26T02:52:35.226Z